[The Problem of Medical Overuse : Finding a Definition and Solutions]

Overview

Journal Internist (Berl)

Specialty General Medicine

Date 2021 Feb 13

PMID 33580822

Citations 2

Authors

T Gamstatter

Affiliations

Soon will be listed here.

Abstract

High-quality medical care including the concepts of "patient-centered medicine" and "precision medicine" imply medical awareness of measures that are "too much" and thus not appropriate for certain patients in a certain context. Physicians occupy a central role as stewards of limited social resources. Numerous influencing factors can cause a cascading into medical overuse. How to identify and avoid overuse? When is "less medicine" the better medicine for an individual patient?

Citing Articles

Surveillance of drug prescribing: why outliers miss their targets - a qualitative study.

Gollnick J, Zeschick N, Horbrand F, Killian P, Sebastiao M, Kuhlein T BMC Health Serv Res. 2025; 25(1):17.

PMID: 39754176 PMC: 11697825. DOI: 10.1186/s12913-024-12189-0.

Exploring the needs and barriers for death education in China: Getting answers from heart transplant recipients' inner experience of death.

Shu W, Miao Q, Feng J, Liang G, Zhang J, Zhang J Front Public Health. 2023; 11:1082979.

PMID: 36860384 PMC: 9968799. DOI: 10.3389/fpubh.2023.1082979.

References

Agoritsas T, Heen A, Brandt L, Alonso-Coello P, Kristiansen A, Akl E . Decision aids that really promote shared decision making: the pace quickens. BMJ. 2015; 350:g7624. PMC: 4707568. DOI: 10.1136/bmj.g7624. View

Berwick D . Avoiding overuse-the next quality frontier. Lancet. 2017; 390(10090):102-104. DOI: 10.1016/S0140-6736(16)32570-3. View

Bishop T, Federman A, Keyhani S . Physicians' views on defensive medicine: a national survey. Arch Intern Med. 2010; 170(12):1081-3. DOI: 10.1001/archinternmed.2010.155. View

Brownlee S, Chalkidou K, Doust J, Elshaug A, Glasziou P, Heath I . Evidence for overuse of medical services around the world. Lancet. 2017; 390(10090):156-168. PMC: 5708862. DOI: 10.1016/S0140-6736(16)32585-5. View

Naci H, Carter A, Mossialos E . Why the drug development pipeline is not delivering better medicines. BMJ. 2015; 351:h5542. DOI: 10.1136/bmj.h5542. View

Casparie A . The ambiguous relationship between practice variation and appropriateness of care: an agenda for further research. Health Policy. 1996; 35(3):247-65. DOI: 10.1016/0168-8510(95)00787-3. View

Cassel C, Guest J . Choosing wisely: helping physicians and patients make smart decisions about their care. JAMA. 2012; 307(17):1801-2. DOI: 10.1001/jama.2012.476. View

Chassin M, Galvin R . The urgent need to improve health care quality. Institute of Medicine National Roundtable on Health Care Quality. JAMA. 1998; 280(11):1000-5. DOI: 10.1001/jama.280.11.1000. View

Almeida C, Choy E, Hewlett S, Kirwan J, Cramp F, Chalder T . Biologic interventions for fatigue in rheumatoid arthritis. Cochrane Database Syst Rev. 2016; (6):CD008334. PMC: 7175833. DOI: 10.1002/14651858.CD008334.pub2. View

10.

Culyer A . The morality of efficiency in health care--some uncomfortable implications. Health Econ. 1992; 1(1):7-18. DOI: 10.1002/hec.4730010105. View

11.

Johnston J, Dhruva S, Ross J, Rathi V . Clinical Evidence Supporting US Food and Drug Administration Clearance of Novel Therapeutic Devices via the De Novo Pathway Between 2011 and 2019. JAMA Intern Med. 2020; 180(12):1701-1703. PMC: 7551221. DOI: 10.1001/jamainternmed.2020.3214. View

12.

Doron S, Davidson L . Antimicrobial stewardship. Mayo Clin Proc. 2011; 86(11):1113-23. PMC: 3203003. DOI: 10.4065/mcp.2011.0358. View

13.

Dumbreck S, Flynn A, Nairn M, Wilson M, Treweek S, Mercer S . Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines. BMJ. 2015; 350:h949. PMC: 4356453. DOI: 10.1136/bmj.h949. View

14.

Elshaug A, Moss J, Littlejohns P, Karnon J, Merlin T, Hiller J . Identifying existing health care services that do not provide value for money. Med J Aust. 2009; 190(5):269-73. DOI: 10.5694/j.1326-5377.2009.tb02394.x. View

15.

Elshaug A, Rosenthal M, Lavis J, Brownlee S, Schmidt H, Nagpal S . Levers for addressing medical underuse and overuse: achieving high-value health care. Lancet. 2017; 390(10090):191-202. DOI: 10.1016/S0140-6736(16)32586-7. View

16.

Freedman L, Cockburn I, Simcoe T . The Economics of Reproducibility in Preclinical Research. PLoS Biol. 2015; 13(6):e1002165. PMC: 4461318. DOI: 10.1371/journal.pbio.1002165. View

17.

Grady D, Redberg R . Less is more: how less health care can result in better health. Arch Intern Med. 2010; 170(9):749-50. DOI: 10.1001/archinternmed.2010.90. View

18.

Grandt D, Gamstatter T, Folsch U . [Recommendations for Drug Treatment in Patients with Multimorbidity]. Dtsch Med Wochenschr. 2020; 145(20):1504-1508. DOI: 10.1055/a-1234-9684. View

19.

Hay M, Thomas D, Craighead J, Economides C, Rosenthal J . Clinical development success rates for investigational drugs. Nat Biotechnol. 2014; 32(1):40-51. DOI: 10.1038/nbt.2786. View

20.

Henderson J, Bouck Z, Holleman R, Chu C, Klamerus M, Santiago R . Comparison of Payment Changes and Choosing Wisely Recommendations for Use of Low-Value Laboratory Tests in the United States and Canada. JAMA Intern Med. 2020; 180(4):524-531. PMC: 7042826. DOI: 10.1001/jamainternmed.2019.7143. View